Abstract
Mild cognitive impairment (MCI) is the transitional stage between normal aging
and Alzheimer’s disease (AD). Impairments in semantic memory have been
demonstrated to be a critical factor in early AD. The Boston Naming Test (BNT)
is a straightforward method of examining semantic or visuo-perceptual processing
and therefore represents a potential diagnostic tool. The objective of this
study was to examine naming ability and identify error types in patients with
amnestic mild cognitive impairment (aMCI).
Collapse